Global X Management Company’s NovoCure NVCR Stock Holding History

Global X Management Company’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$54K	Buy	+1,730	New	+$48.1K	﹤0.01%	1072
2017 Q2	–	Sell	-311	Closed	-$3K	–	1221
2017 Q1	$3K	Hold	311	–	–	﹤0.01%	1193
2016 Q4	$2K	Buy	311 +17	+6%	+$137	﹤0.01%	1087
2016 Q3	$3K	Hold	294	–	–	﹤0.01%	1083
2016 Q2	$3K	Buy	+294	New	+$3.68K	﹤0.01%	974

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Global X Management Company's NVCR Position: Q2 2018 in Review

Global X Management Company opened a new position in NovoCure (NVCR) in Q2 2018: 1,730 shares worth $54K. The stake represents ﹤0.01% of the portfolio and ranks #1072 among its holdings. This is a return to the name: Global X Management Company previously reported a position in NVCR as recently as Q1 2017.

Global X Management Company first reported a position in NVCR in Q2 2016 and has held it in 5 quarters since. 161 funds tracked by Wall St. Rank hold NVCR as of Q2 2018.

Global X Management Company held 1,730 shares of NovoCure worth $54K as of Q2 2018.
NovoCure was a new Global X Management Company position in Q2 2018.
NovoCure made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1072 holding.
Global X Management Company first reported a position in NovoCure in Q2 2016 and has held it in 5 quarters since.
161 funds tracked by Wall St. Rank held NovoCure as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.